{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:54:56Z","timestamp":1761929696294,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013262","name":"State Key Laboratory of Respiratory Disease","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["154144KYSB20190005"],"award-info":[{"award-number":["154144KYSB20190005"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016098","name":"Special Project for Marine Economy Development of Guangdong Province","doi-asserted-by":"publisher","award":["SKLRD-OP-201919","SKLRD-Z-202016","GDME-2018C003"],"award-info":[{"award-number":["SKLRD-OP-201919","SKLRD-Z-202016","GDME-2018C003"]}],"id":[{"id":"10.13039\/100016098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016305","name":"First Affiliated Hospital of Zhengzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.apsb.2020.11.007","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T04:25:31Z","timestamp":1605241531000},"page":"738-749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Ultra-short-course and intermittent TB47-containing oral regimens produce stable cure against Buruli ulcer in a murine model and prevent the emergence of resistance for Mycobacterium ulcerans"],"prefix":"10.1016","volume":"11","author":[{"given":"Yamin","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.M. Adnan","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingmin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiting","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xirong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhili","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7264-5180","authenticated-orcid":false,"given":"Md Mahmudul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5647-6014","authenticated-orcid":false,"given":"Tianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2020.11.007_bib1","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(99)01156-3","article-title":"Mycobacterium ulcerans infection","volume":"354","author":"van der Werf","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2020.11.007_bib2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.283.5403.854","article-title":"Mycolactone: A polyketide toxin from Mycobacterium ulcerans required for virulence","volume":"283","author":"George","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.apsb.2020.11.007_bib3","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1128\/AAC.49.8.3182-3186.2005","article-title":"Efficacy of the combination rifampin\u2013streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans","volume":"49","author":"Etuaful","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2020.11.007_bib4","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/AAC.00299-10","article-title":"Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease","volume":"54","author":"Sarfo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2020.11.007_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006728","article-title":"Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer","volume":"12","author":"Converse","year":"2018","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.apsb.2020.11.007_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003823","article-title":"Efficacy of rifampin plus clofazimine in a murine model of Mycobacterium ulcerans disease","volume":"9","author":"Converse","year":"2015","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.apsb.2020.11.007_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005066","article-title":"Sterilizing activity of fully oral intermittent regimens against Mycobacterium ulcerans infection in mice","volume":"10","author":"Chauffour","year":"2016","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.apsb.2020.11.007_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00426-19","article-title":"Shortening Buruli ulcer treatment with combination therapy targeting the respiratory chain and exploiting Mycobacterium ulcerans gene decay","volume":"63","author":"Converse","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2020.11.007_bib9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41467-019-08464-y","article-title":"The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model","volume":"10","author":"Liu","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2020.11.007_bib10","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.apsb.2019.05.002","article-title":"Hypericin enhances beta-lactam antibiotics activity by inhibiting sarA expression in methicillin-resistant Staphylococcus aureus","volume":"9","author":"Wang","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2020.11.007_bib11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.apsb.2019.01.017","article-title":"In\u00a0vitro and in\u00a0vivo activity of d-serine in combination with beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus","volume":"9","author":"Wang","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2020.11.007_bib12","doi-asserted-by":"crossref","first-page":"e2598","DOI":"10.1371\/journal.pntd.0002598","article-title":"Rapid, serial, non-invasive assessment of drug efficacy in mice with autoluminescent Mycobacterium ulcerans infection","volume":"7","author":"Zhang","year":"2013","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.apsb.2020.11.007_bib13","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1128\/AAC.00400-10","article-title":"Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains","volume":"54","author":"Zhang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2020.11.007_bib14","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1128\/AAC.46.10.3193-3196.2002","article-title":"Bactericidal activity of rifampin\u2013amikacin against Mycobacterium ulcerans in mice","volume":"46","author":"Dega","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2020.11.007_bib15","doi-asserted-by":"crossref","first-page":"12393","DOI":"10.1038\/ncomms12393","article-title":"Turning the respiratory flexibility of Mycobacterium tuberculosis against itself","volume":"7","author":"Lamprecht","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2020.11.007_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01881-19","article-title":"Assessment of clofazimine and TB47 combination activity against Mycobacterium abscessus using a bioluminescent approach","volume":"64","author":"Liu","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2020.11.007_bib17","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1128\/AAC.01123-07","article-title":"In\u00a0vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis","volume":"51","author":"Almeida","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2020.11.007_bib18","doi-asserted-by":"crossref","first-page":"e933","DOI":"10.1371\/journal.pntd.0000933","article-title":"Activities of rifampin, rifapentine and clarithromycin alone and in combination against Mycobacterium ulcerans disease in mice","volume":"5","author":"Almeida","year":"2011","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.apsb.2020.11.007_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01478-18","article-title":"High-dose rifamycins enable shorter oral treatment in a murine model of Mycobacterium ulcerans disease","volume":"63","author":"Omansen","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2020.11.007_bib20","article-title":"Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening","volume":"13","author":"Phillips","year":"2019","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.apsb.2020.11.007_bib21","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/imj.13511","article-title":"Antibiotic complications during the treatment of Mycobacterium ulcerans disease in Australian patients","volume":"47","author":"O'Brien","year":"2017","journal-title":"Intern Med J"},{"key":"10.1016\/j.apsb.2020.11.007_bib22","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1517\/14656566.6.16.2867","article-title":"Clarithromycin extended-release in community-acquired respiratory tract infections","volume":"6","author":"Williams","year":"2006","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.apsb.2020.11.007_bib23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1164\/rccm.201206-1088OC","article-title":"Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease","volume":"186","author":"Koh","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.apsb.2020.11.007_bib24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/infdis\/171.3.747","article-title":"Reduced serum levels of clarithromycin in patients treated with multi-drug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection","volume":"3","author":"Wallace","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.apsb.2020.11.007_bib25","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1128\/AAC.47.4.1228-1232.2003","article-title":"Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice","volume":"47","author":"Marsollier","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2020.11.007_bib26","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/clpt.2011.323","article-title":"Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers","volume":"91","author":"Dooley","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2020.11.007_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1164\/rccm.201410-1843OC","article-title":"Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial","volume":"191","author":"Dorman","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.apsb.2020.11.007_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fcimb.2018.00114","article-title":"Molecular targets related drug resistance mechanisms in MDR-, XDR, and TDR-Mycobacterium tuberculosis strains","volume":"8","author":"Hameed","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.apsb.2020.11.007_bib29","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.3262","article-title":"Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis","volume":"19","author":"Pethe","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2020.11.007_bib30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/acsinfecdis.8b00225","article-title":"Pyrazolo[1,5-a] pyridine inhibitor of the respiratory cytochrome bcc complex for the treatment of drug-resistant tuberculosis","volume":"5","author":"Lu","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2020.11.007_bib31","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/bkcs.10765","article-title":"Putative 3D structure of QcrB from Mycobacterium tuberculosis cytochromebc1 complex, a novel drug-target for new series of antituberculosis agent Q203","volume":"37","author":"Ko","year":"2016","journal-title":"Bull Kor Chem Soc"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383520307966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383520307966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:48:14Z","timestamp":1761929294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383520307966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2211383520307966"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2020.11.007","relation":{},"ISSN":["2211-3835"],"issn-type":[{"type":"print","value":"2211-3835"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultra-short-course and intermittent TB47-containing oral regimens produce stable cure against Buruli ulcer in a murine model and prevent the emergence of resistance for Mycobacterium ulcerans","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2020.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}